Lampa, Angel B.

HRN: 21-11-83  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/13/2022
06/20/2022
IVT
188mg
Q6
PCAP C
Waiting Final Action 
06/17/2022
CEFTRIAXONE 1G (VIAL)
06/17/2022
06/23/2022
IVT
500mg
OD
PCAP C
Waiting Final Action 
06/17/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/17/2022
06/23/2022
IVT
75mg
OD
PCAP C
Waiting Final Action 
07/20/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/20/2022
07/26/2022
IV
540mg
Q8Hrs
PCAP-C
Waiting Final Action 
07/20/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/20/2022
07/26/2022
IV
81mg
Q24Hrs
PCAP-C
Waiting Final Action 
07/26/2022
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
07/26/2022
07/31/2022
ORAL
1.5 Ml
24 Hrs
PCAP C; PTB
Waiting Final Action 
12/15/2022
CEFUROXIME 750MG (VIAL)
12/15/2022
12/22/2022
IV
220mg
Q8
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: